Mechanisms of ischemic injury are different in the steatotic and normal rat liver.
Détails
ID Serval
serval:BIB_E3001B86FBCA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Mechanisms of ischemic injury are different in the steatotic and normal rat liver.
Périodique
Hepatology
ISSN
0270-9139 (Print)
ISSN-L
0270-9139
Statut éditorial
Publié
Date de publication
2000
Volume
32
Numéro
6
Pages
1280-1288
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, U.S. Gov't, P.H.S.Publication Status: ppublish
Résumé
Hepatic steatosis is associated with significant morbidity and mortality after liver resection and transplantation. Although apoptosis is a key mechanism of reperfusion injury in the normal liver, the pathway leading to cell death in steatotic hepatocytes is unknown. A model of hepatic ischemia and reperfusion injury in fatty and lean Zucker rats was used. Fatty animals had increased aspartate aminotransferase (AST) release and decreased survival after 60 minutes of ischemia compared with lean animals. Apoptosis was the predominant form of cell death in the lean rats (82%), whereas necrosis was minimal. In contrast, fatty animals developed only moderate amounts of apoptosis but showed massive necrosis (73%) after 24 hours of reperfusion. Intracellular mediators of apoptosis, such as caspase 8, caspase 3, and cytochrome c, were significantly lower in the steatotic than in the lean liver indicating dysfunction in activation of the apoptotic pathway. The high percentage of necrosis in the steatotic rats was associated with renal acute tubular necrosis after 24 hours of reperfusion in the fatty, but not in lean rats. Caspase inhibition significantly decreased reperfusion injury in lean animals, but was ineffective in fatty animals. The results indicate that the increased susceptibility of fatty livers to reperfusion injury is associated with a change from an apoptotic form of cell death to necrosis. We conclude that new therapeutic strategies are necessary in the fatty liver.
Mots-clé
Animals, Apoptosis/drug effects, Blood Pressure, Caspases/antagonists & inhibitors, Enzyme Inhibitors/pharmacology, Fatty Liver/complications, Fatty Liver/pathology, Indoles/pharmacology, Ischemia/complications, Ischemia/pathology, Kidney Diseases/etiology, Liver/pathology, Liver Circulation, Lung Diseases/etiology, Male, Necrosis, Oligopeptides/pharmacology, Portal Vein/physiopathology, Rats, Rats, Zucker, Reperfusion Injury/complications, Reperfusion Injury/pathology, Thinness
Pubmed
Web of science
Open Access
Oui
Création de la notice
13/02/2012 8:50
Dernière modification de la notice
20/08/2019 16:06